Belatacept Combined With Transient Calcineurin Inhibitor Therapy Prevents Rejection and Promotes Improved Long-Term Renal Allograft Function.
Am J Transplant
; 17(11): 2922-2936, 2017 Nov.
Article
em En
| MEDLINE
| ID: mdl-28544101
Palavras-chave
clinical research/practice; costimulation; fusion proteins and monoclonal antibodies: belatacept; fusion proteins and monoclonal antibodies: costimulation molecule specific; health services and outcomes research; immunosuppressant; immunosuppression/immune modulation; kidney (allograft) function/dysfunction; kidney transplantation/nephrology; rejection: T cell mediated (TCMR)
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Transplante de Rim
/
Abatacepte
/
Rejeição de Enxerto
/
Sobrevivência de Enxerto
/
Isoanticorpos
/
Falência Renal Crônica
Tipo de estudo:
Etiology_studies
/
Guideline
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limite:
Adult
/
Female
/
Humans
/
Male
/
Middle aged
Idioma:
En
Ano de publicação:
2017
Tipo de documento:
Article